Status:
NOT_YET_RECRUITING
Dual Mobility Cup Versus Unipolar Cup
Lead Sponsor:
Northern Orthopaedic Division, Denmark
Conditions:
Dislocation, Hip
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The general purpose of this study is to examine whether the dual mobility cup (Novae® Serf) reduces the number of hip dislocations after total hip replacement, both early dislocation (≤1 year) and lat...
Detailed Description
Surgery with THR for arthritis and other hip disorders has long been one of the most successful orthopedic surgical treatments. The majority of the patients gain pain relief and experience improved hi...
Eligibility Criteria
Inclusion
- Patients with hip arthritis who are amenable to surgery with THR and age ≥ 65 years referred to the Department of Orthopedic Surgery at either Section Farsø, Frederikshavn Hospital or Aalborg University Hospital. Patients who are willing to participate in the trial and who give their written, informed consent after receiving oral and written information.
Exclusion
- Patients who do not wish to participate.
- Sequelae of Calvé-Legg-Perthes' disease, caput necrosis, epiphysiolysis.
- Proximal femoral or acetabular fracture.
- Hip dysplasia with subluxation Crowe types III and IV.
- Earlier hip bone surgery (excluding arthroscopic surgery).
- Elective bilateral surgery.
- If the patient's bone morphology is unsuitable for a cemented Exeter® femoral stem.
- Patients with no e-mail.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04685239
Start Date
April 1 2023
End Date
December 1 2035
Last Update
March 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Northen Denmark, Denmark, 9000